This information was published on 2026-07-09T15:51:01 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2665938 (IR 1924425) |
| (220) |
27 Apr 2026
|
| (300) |
US, 29 Oct 2025, 99468188
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of infectious diseases; medicinal preparations for the treatment and prevention of cancer and infectious diseases, including coronavirus, for administration as a vaccine; pharmaceutical preparations for the prevention of infectious diseases, including coronavirus, for administration as a vaccine; pharmaceutical preparations for the treatment of cancer, including coronavirus, for administration as a vaccine; pharmaceutical preparations for the prevention of cancer, including coronavirus, for administration as a vaccine; biological preparations for the prevention and treatment of cancer and infectious diseases, including coronavirus, for administration as a vaccine. |
| (540) | COVRYX |
| (550) | Word |
| (730) |
ImmunityBio, Inc.
|
Find out more about publications on the About page.